Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Tempus Labs is raising $9,999,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Eric Lefkofsky played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Tempus Labs
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. Our mission is for each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data. Its About Time.

To learn more about Tempus Labs, visit http://www.tempus.com/

Contact:
Eric Lefkofsky, Chief Executive Officer
800-976-5448
https://www.linkedin.com/in/ericlefkofsky/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved